Biological effects of resveratrol

被引:406
作者
Bhat, KPL
Kosmeder, JW
Pezzuto, JM [1 ]
机构
[1] Univ Illinois, Program Collaborat Res Pharmaceut Sci, Chicago, IL 60612 USA
[2] Univ Illinois, Ctr Canc, Chicago, IL 60612 USA
[3] Univ Illinois, Dept Med Chem & Pharmacognosy, Coll Pharm, Chicago, IL 60612 USA
关键词
D O I
10.1089/152308601317203567
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Resveratrol (3,4',5-trihydroxy-trans-stilbene) is a common phytoalexin that is found in a few edible materials, such as grape skins, peanuts, and red wine. It has been speculated that dietary resveratrol may act as an antioxidant, promote nitric oxide production, inhibit platelet aggregation, and increase high-density lipoprotein cholesterol, and thereby serve as a cardioprotective agent. Based on epidemiological data, carcinogenesis and coronary heart disease are linked to dietary lifestyle and share a number of common pathways. Recently, it has been demonstrated that resveratrol can function as a cancer chemopreventive agent, and there has been a great deal of experimental effort directed toward defining this effect. Resveratrol has been reported to be estrogenic in transfected mammary cancer cells; however, there are conflicting results with respect to its actual estrogenic properties. In addition, resveratrol exhibits anti inflammatory, neuroprotective, and antiviral properties. In future work, some controversial in vitro biological effects need to be explored in animal models, and relevant physiological and pharmacological concentrations need to be used when assessing biological activities. This review focuses on various biological aspects of resveratrol and some issues that need to be addressed to gain a fuller appreciation of potential health benefits for human beings.
引用
收藏
页码:1041 / 1064
页数:24
相关论文
共 156 条
  • [11] Interaction of transresveratrol with plasma lipoproteins
    Belguendouz, L
    Frémont, L
    Gozzelino, MT
    [J]. BIOCHEMICAL PHARMACOLOGY, 1998, 55 (06) : 811 - 816
  • [12] CLINICAL CHEMOPREVENTION - DEVELOPING A CANCER PREVENTION STRATEGY
    BENNER, SE
    HONG, WK
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (18) : 1446 - 1447
  • [13] BERHARD D, 2000, CELL DEATH DIFFER, V7, P834
  • [14] Bertelli AAE, 1999, INT J TISSUE REACT, V21, P93
  • [15] Bertelli AAE, 1996, DRUG EXP CLIN RES, V22, P61
  • [16] BERTELLI AAE, 1995, INT J TISSUE REACT, V17, P1
  • [17] Blardi P, 1999, DRUG EXP CLIN RES, V25, P105
  • [18] Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β
    Bowers, JL
    Tyulmenkov, VV
    Jernigan, SC
    Klinge, CM
    [J]. ENDOCRINOLOGY, 2000, 141 (10) : 3657 - 3667
  • [19] Bradamante S, 2000, INT J TISSUE REACT, V22, P1
  • [20] BRUNE M, 1989, EUR J CLIN NUTR, V43, P547